Innoviva, Inc. (INVA): Price and Financial Metrics

INVA POWR Grades

• Value is the dimension where INVA ranks best; there it ranks ahead of 95.01% of US stocks.
• The strongest trend for INVA is in Value, which has been heading down over the past 26 weeks.
• INVA ranks lowest in Momentum; there it ranks in the 18th percentile.

INVA Stock Summary

• Over the past twelve months, INVA has reported earnings growth of -77.7%, putting it ahead of merely 17.28% of US stocks in our set.
• As for revenue growth, note that INVA's revenue has grown -22.18% over the past 12 months; that beats the revenue growth of merely 12.49% of US companies in our set.
• INNOVIVA INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 15.72%, greater than the shareholder yield of 89.35% of stocks in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to INNOVIVA INC are DVAX, VREX, MNKD, ETSY, and JAZZ.
• INVA's SEC filings can be seen here. And to visit INNOVIVA INC's official web site, go to www.inva.com.

INVA Valuation Summary

• INVA's price/sales ratio is 3.5; this is 16.67% lower than that of the median Healthcare stock.
• INVA's EV/EBIT ratio has moved up 22.3 over the prior 234 months.

Below are key valuation metrics over time for INVA.

INVA Growth Metrics

The 4 year net income to common stockholders growth rate now stands at 162.61%.
• The 4 year revenue growth rate now stands at 89.82%.
• Its 2 year cash and equivalents growth rate is now at -38.41%.

INVA's revenue has moved up $223,331,000 over the prior 67 months.

The table below shows INVA's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	373.216	291.208	292.58
2022-06-30	403.821	372.229	99.495
2022-03-31	396.407	377.808	187.504
2021-12-31	391.866	363.813	265.854
2021-12-31	391.866	363.813	265.854
2021-09-30	374.662	350.712	309.412

INVA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• INVA has a Quality Grade of B, ranking ahead of 77.13% of graded US stocks.
• INVA's asset turnover comes in at 0.398 -- ranking 118th of 682 Pharmaceutical Products stocks.
• LUMO, RETA, and SUPN are the stocks whose asset turnover ratios are most correlated with INVA.

The table below shows INVA's key quality metrics over time.